Intrapleural adaptive immunotherapy for breast cancer patients with cytologically-confirmed malignant pleural effusions: an analysis of 67 patients in Kyoto and Shiga Prefecture, Japan-Reference-Cited by-同舟云学术

Intrapleural adaptive immunotherapy for breast cancer patients with cytologically-confirmed malignant pleural effusions: an analysis of 67 patients in Kyoto and Shiga Prefecture, Japan

Published:1993 Issue:3 Volume:27 Page:203-210
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Kan Norimichi,Kodama Hiroshi,Hori Taisuke,Takenaka Atsushi,Yasumura Tadaki,Kato Hirofumi,Ogawa Hiroki,Mukaihara Sumio,Kudo Takashi,Ohsumi Kiyoshi,Mise Keiichi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00665690.pdf

Reference14 articles.

1. Rosato SE, Wallach MW, Rosato EF: The management of malignant effusions from breast cancer. J Surg Oncol 6: 441?449, 1974

2. Anderson CB, Philpott GW, Ferguson TB: The treatment of malignant pleural effusions. Cancer 33: 916?922, 1974

3. Chernow B, Sahn SA: Carcinomatous involvement of the pleura: An analysis of 96 patients. Am J Med 63: 695?702, 1977

4. Raju RN, Kardinal CG: Pleural effusion in breast cancer: Analysis of 122 cases. Cancer 48: 2524?2527, 1981

5. Molengraft FJJM, Vooijs GP: Survival of patients with malignancy-associated effusions. Acta Cytologica 33: 911?916, 1989

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Thoracic Tumors;Cancers;2024-07-11

2. Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis;Thoracic Cancer;2022-02-22

3. Breast Cancer;Serous Effusions;2018

4. Breast Cancer;Serous Effusions;2011-10-04

5. Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patients;Cancer Immunology, Immunotherapy;2010-06-01